100 ML eptifibatide 0.75 MG/ML Injection — RxCUI 200349
RxNorm drug concept · Semantic clinical drug
RxCUI 200349
Semantic clinical drug · SCD
● Current RxNorm concept 21 FDA products
21 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI200349
Official name100 ML eptifibatide 0.75 MG/ML Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known aseptifibatide 75 MG per 100 ML Injection; eptifibatide 75 MG in 100 ML Injection
FDA products mapped21
Package NDCs mapped21
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
🕸️ Concept Web — How 100 ML eptifibatide 0.75 MG/ML Injection Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
100 ML eptifibatide 0.75 MG/ML Injection
RxCUI 200349 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Eptifibatide
75635IN
-
Eptifibatide
-
Dose forms 4
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Eptifibatide Injection
1736469SCDF -
Eptifibatide Injectable Product
1161927SCDG -
Injection
1649574DF -
Injectable Product
1151126DFG
-
Eptifibatide Injection
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Eptifibatide 0.75 MG/ML
315863SCDC
-
Eptifibatide 0.75 MG/ML
Showing up to 8 concepts per family — 6 of 6 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Eptifibatide 0.75 MG/ML
SCDC · 315863 -
Eptifibatide Injection
SCDF · 1736469 -
Eptifibatide Injectable Product
SCDG · 1161927
📦 FDA Products & Package NDCs
21 products · 21 package NDCs
21 package NDCs map to RxCUI 200349 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00338-9558-10 | 1 VIAL, SINGLE-DOSE in 1 CARTON (0338-9558-10) / 100 mL in... | Eptifibatide | Baxter Healthcare Company | 2019-02-01 |
| 25021-0408-51 | 1 VIAL in 1 CARTON (25021-408-51) / 100 mL in 1 VIAL | eptifibatide | Sagent Pharmaceuticals | 2018-07-15 |
| 52958-0040-01 | 1 VIAL, SINGLE-DOSE in 1 CARTON (52958-040-01) / 100 mL in... | Eptifibatide | Hainan Shuangcheng Pharmaceuticals Co., Ltd. | 2022-04-21 |
| 52958-0402-01 | 1 VIAL, SINGLE-DOSE in 1 CARTON (52958-402-01) / 10 mL in 1... | Eptifibatide | Hainan Shuangcheng Pharmaceuticals Co., Ltd. | 2021-09-07 |
| 55150-0218-99 | 1 VIAL, SINGLE-DOSE in 1 CARTON (55150-218-99) / 100 mL in... | Eptifibatide | Eugia US LLC | 2015-12-08 |
| 55150-0219-10 | 1 VIAL, SINGLE-DOSE in 1 CARTON (55150-219-10) / 10 mL in 1... | Eptifibatide | Eugia US LLC | 2015-12-08 |
| 55150-0220-99 | 1 VIAL, SINGLE-DOSE in 1 CARTON (55150-220-99) / 100 mL in... | Eptifibatide | Eugia US LLC | 2015-12-08 |
| 67457-0629-10 | 1 VIAL in 1 CARTON (67457-629-10) / 10 mL in 1 VIAL | Eptifibatide | Mylan Institutional LLC | 2018-10-01 |
| 67457-0630-10 | 1 VIAL in 1 CARTON (67457-630-10) / 100 mL in 1 VIAL | Eptifibatide | Mylan Institutional LLC | 2018-10-01 |
| 67457-0631-10 | 1 VIAL in 1 CARTON (67457-631-10) / 100 mL in 1 VIAL | Eptifibatide | Mylan Institutional LLC | 2018-12-13 |
| 70436-0026-80 | 10 mL in 1 VIAL (70436-026-80) | Eptifibatide | Slate Run Pharmaceuticals, LLC | 2019-07-22 |
| 70436-0027-80 | 100 mL in 1 VIAL (70436-027-80) | Eptifibatide | Slate Run Pharmaceuticals, LLC | 2019-07-22 |
| 70436-0162-80 | 10 mL in 1 VIAL (70436-162-80) | Eptifibatide | Slate Run Pharmaceuticals, LLC | 2020-12-01 |
| 70436-0163-80 | 100 mL in 1 VIAL (70436-163-80) | Eptifibatide | Slate Run Pharmaceuticals, LLC | 2020-12-01 |
| 71288-0412-10 | 1 VIAL, SINGLE-DOSE in 1 CARTON (71288-412-10) / 10 mL in 1... | Eptifibatide | Meitheal Pharmaceuticals Inc. | 2024-05-09 |
| 71288-0413-51 | 1 VIAL, SINGLE-DOSE in 1 CARTON (71288-413-51) / 100 mL in... | Eptifibatide | Meitheal Pharmaceuticals Inc. | 2024-05-09 |
| 72078-0025-10 | 1 VIAL in 1 CARTON (72078-025-10) / 10 mL in 1 VIAL | Eptifibatide | Mylan Institutional LLC | 2021-04-01 |
| 72078-0026-10 | 1 VIAL in 1 CARTON (72078-026-10) / 100 mL in 1 VIAL | Eptifibatide | Mylan Institutional LLC | 2020-11-20 |
| 72078-0027-10 | 1 VIAL in 1 CARTON (72078-027-10) / 100 mL in 1 VIAL | Eptifibatide | Mylan Institutional LLC | 2021-04-01 |
| 83634-0300-10 | 1 VIAL, SINGLE-DOSE in 1 CARTON (83634-300-10) / 10 mL in 1... | Eptifibatide | Avenacy Inc. | 2024-01-31 |
| 83634-0301-51 | 1 VIAL, SINGLE-DOSE in 1 CARTON (83634-301-51) / 100 mL in... | Eptifibatide | Avenacy Inc. | 2024-01-31 |
Observed labelers:
Mylan Institutional LLC (6) ·
Slate Run Pharmaceuticals, LLC (4) ·
Eugia US LLC (3) ·
Avenacy Inc. (2) ·
Hainan Shuangcheng Pharmaceuticals Co., Ltd. (2) ·
Meitheal Pharmaceuticals Inc. (2)
· +2 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.